These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34015408)

  • 1. Exploring role of polysaccharides present in Ganoderma lucidium extract powder and probiotics as solid carriers in development of liquisolid formulation loaded with quercetin: A novel study.
    Khursheed R; Singh SK; Gulati M; Wadhwa S; Kapoor B; Pandey NK; Chellappan DK; Gupta G; Jha NK; Dua K; Kapoor DN; Karri VVSR; Pattanayak P; Sharni A; Mondal S
    Int J Biol Macromol; 2021 Jul; 183():1630-1639. PubMed ID: 34015408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of mushroom polysaccharide and probiotics based solid self-nanoemulsifying drug delivery system loaded with curcumin and quercetin to improve their dissolution rate and permeability: State of the art.
    Khursheed R; Singh SK; Wadhwa S; Gulati M; Kapoor B; Jain SK; Gowthamarajan K; Zacconi F; Chellappan DK; Gupta G; Jha NK; Gupta PK; Dua K
    Int J Biol Macromol; 2021 Oct; 189():744-757. PubMed ID: 34464640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-nanoemulsifying composition containing curcumin, quercetin, Ganoderma lucidum extract powder and probiotics for effective treatment of type 2 diabetes mellitus in streptozotocin induced rats.
    Khursheed R; Singh SK; Kumar B; Wadhwa S; Gulati M; A A; Awasthi A; Vishwas S; Kaur J; Corrie L; K R A; Kumar R; Jha NK; Gupta PK; Zacconi F; Dua K; Chitranshi N; Mustafa G; Kumar A
    Int J Pharm; 2022 Jan; 612():121306. PubMed ID: 34813906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring role of probiotics and Ganoderma lucidum extract powder as solid carriers to solidify liquid self-nanoemulsifying delivery systems loaded with curcumin.
    Khursheed R; Singh SK; Wadhwa S; Gulati M; Awasthi A; Kumar R; Ramanunny AK; Kapoor B; Kumar P; Corrie L
    Carbohydr Polym; 2020 Dec; 250():116996. PubMed ID: 33049905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation Development of Mirtazapine Liquisolid Compacts: Optimization Using Central Composite Design.
    Naureen F; Shah Y; Shah SI; Abbas M; Rehman IU; Muhammad S; Hamdullah H; Goh KW; Khuda F; Khan A; Chan SY; Mushtaq M; Ming LC
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suitability of various excipients as carrier and coating materials for liquisolid compacts.
    Hentzschel CM; Sakmann A; Leopold CS
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1200-7. PubMed ID: 21449826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.
    Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C
    Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction.
    Natesan S; Pandian S; Ponnusamy C; Palanichamy R; Muthusamy S; Kandasamy R
    Int J Biol Macromol; 2017 Nov; 104(Pt B):1837-1845. PubMed ID: 28472691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation factors affecting the release of ezetimibe from different liquisolid compacts.
    Khanfar M; Sheikh Salem M; Hawari R
    Pharm Dev Technol; 2013; 18(2):417-27. PubMed ID: 22530561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and evaluation of liquisolid compacts for olmesartan medoxomil.
    Prajapati ST; Bulchandani HH; Patel DM; Dumaniya SK; Patel CN
    J Drug Deliv; 2013; 2013():870579. PubMed ID: 24232077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
    Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
    Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation.
    Jaipakdee N; Limpongsa E; Sripanidkulchai BO; Piyachaturawat P
    Int J Pharm; 2018 Dec; 553(1-2):157-168. PubMed ID: 30316793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of liquisolid formulations on dissolution of naproxen.
    Tiong N; Elkordy AA
    Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of ketoconazole dissolution rate by the liquisolid technique.
    Molaei MA; Osouli-Bostanabad K; Adibkia K; Shokri J; Asnaashari S; Javadzadeh Y
    Acta Pharm; 2018 Sep; 68(3):325-336. PubMed ID: 31259692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquisolid system of paclitaxel using modified polysaccharides: In vitro cytotoxicity, apoptosis study, cell cycle analysis, in vitro mitochondrial membrane potential assessment, and pharmacokinetics.
    Sharma V; Pathak K
    Int J Biol Macromol; 2019 Sep; 137():20-31. PubMed ID: 31252010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial analysis of quercetin and resveratrol by HPTLC in
    Sethuraman V; Janakiraman K; Krishnaswami V; Natesan S; Kandasamy R
    Nat Prod Res; 2021 Jul; 35(13):2243-2248. PubMed ID: 31496285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of powder substrate on the dissolution properties of methyclothiazide liquisolid compacts.
    Spireas S; Wang T; Grover R
    Drug Dev Ind Pharm; 1999 Feb; 25(2):163-8. PubMed ID: 10065349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of Loperamide Dissolution Rate by Liquisolid Compact Technique.
    Venkateswarlu K; Preethi JK; Chandrasekhar KB
    Adv Pharm Bull; 2016 Sep; 6(3):385-390. PubMed ID: 27766222
    [No Abstract]   [Full Text] [Related]  

  • 19. Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles.
    Elkordy AA; Essa EA; Dhuppad S; Jammigumpula P
    Int J Pharm; 2012 Sep; 434(1-2):122-32. PubMed ID: 22677418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
    Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M
    J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.